PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Fucoxanthin also regulated the lipid metabolism, oxidative stress, and inflammation via the AMPK/Nrf2/TLR4 signaling pathway and attenuated free fatty acid-induced NAFLD [123].